JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BSTC
3626
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $589K | ﹤0.01% |
9,609
-619
| -6% | -$35.8K |
2017 Q4
10 quarters
|
|
3627
ADT
ADT
$4.54B
| $588K | ﹤0.01% |
73,608
+73,570
| +193,605% | +$476K |
2018 Q1
9 quarters
|
|
|
ACRE
3628
Ares Commercial Real Estate
ACRE
$205M
| $587K | ﹤0.01% |
64,409
+3,326
| +5% | +$25.9K |
2015 Q3
19 quarters
|
|
|
FCBP
3629
DELISTED
First Choice Bancorp Common Stock
FCBP
| $587K | ﹤0.01% |
35,824
+11,720
| +49% | +$170K |
2018 Q2
8 quarters
|
|
|
PRVL
3630
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $585K | ﹤0.01% |
39,253
+7,258
| +23% | +$112K |
2019 Q3
3 quarters
|
|
|
KRTX
3631
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $582K | ﹤0.01% |
5,228
+1,841
| +54% | +$160K |
2019 Q2
4 quarters
|
|
3632
Gladstone Capital
GLAD
$432M
| $581K | ﹤0.01% |
39,750
-7,176
| -15% | -$95.3K |
2015 Q4
18 quarters
|
|
|
BNY
3633
CALL
Bank of New York Mellon
BNY
$97.5B
| $580K | ﹤0.01% |
15,000
| – | – |
2017 Q3
11 quarters
|
|
|
BNY
3634
PUT
Bank of New York Mellon
BNY
$97.5B
| $580K | ﹤0.01% |
15,000
| – | – |
2017 Q3
11 quarters
|
|
|
RC
3635
Ready Capital
RC
$182M
| $580K | ﹤0.01% |
66,691
+33,298
| +100% | +$226K |
2016 Q1
17 quarters
|
|
3636
Cooper-Standard Automotive
CPS
$391M
| $575K | ﹤0.01% |
43,456
+27,309
| +169% | +$331K |
2016 Q1
17 quarters
|
|
3637
Midland States Bancorp
MSBI
$685M
| $575K | ﹤0.01% |
38,445
-4,634
| -11% | -$71.3K |
2016 Q3
15 quarters
|
|
3638
PUT
Norwegian Cruise Line
NCLH
$6.83B
| $575K | ﹤0.01% |
35,000
-15,000
| -30% | -$220K |
2020 Q1
1 quarter
|
|
3639
ASE Group
ASX
$124B
| $569K | ﹤0.01% |
125,269
+16,051
| +15% | +$68.5K |
2013 Q2
28 quarters
|
|
3640
State Street SPDR Dow Jones International Real Estate ETF
RWX
$239M
| $569K | ﹤0.01% |
19,741
-6,255
| -24% | -$177K |
2014 Q4
22 quarters
|
|
|
CDMO
3641
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $569K | ﹤0.01% |
86,683
-66,535
| -43% | -$371K |
2015 Q1
21 quarters
|
|
|
AZUL
3642
PUT
DELISTED
Azul
AZUL
| $567K | ﹤0.01% |
+50,700
| New | +$488K |
2020 Q2
0 quarters
|
|
3643
Invesco Pharmaceuticals ETF
PJP
$547M
| $566K | ﹤0.01% |
8,756
-892
| -9% | -$55.4K |
2014 Q4
22 quarters
|
|
|
ALTR
3644
DELISTED
Altair Engineering Inc
ALTR
| $564K | ﹤0.01% |
14,205
+1,015
| +8% | +$34.5K |
2018 Q2
8 quarters
|
|
3645
CorVel
CRVL
$3.84B
| $563K | ﹤0.01% |
23,874
+10,872
| +84% | +$214K |
2015 Q4
18 quarters
|
|
3646
First Mid Bancshares
FMBH
$1.32B
| $563K | ﹤0.01% |
21,465
-17,949
| -46% | -$450K |
2017 Q4
10 quarters
|
|
|
ISEE
3647
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $561K | ﹤0.01% |
109,967
+92,694
| +537% | +$386K |
2020 Q1
1 quarter
|
|
3648
Liberty Global Class A
LBTYA
$3.07B
| $560K | ﹤0.01% |
25,612
-819
| -3% | -$16.9K |
2013 Q2
28 quarters
|
|
|
MMAC
3649
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $559K | ﹤0.01% |
24,187
+6,565
| +37% | +$163K |
2019 Q1
5 quarters
|
|
3650
Genpact
G
$5.61B
| $558K | ﹤0.01% |
15,275
-148,745
| -91% | -$5.03M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.